Clinical trial Recruiting at 1 site Interventional Ages 18 to 80

Using two coils of magnetic stimulation to measure and modulate brain inhibition after stroke

Official title: Using Dual-coil Transcranial Magnetic Stimulation to Measure and Modulate Poststroke Interhemispheric Inhibition (IHI): A Concurrent TMS-EEG-EMG Study

Run by The Hong Kong Polytechnic University · NCT07431749 · Data updated 2026-11-12

This study tests a new TMS-EEG method to measure interhemispheric inhibition after stroke and compares it with the standard TMS-EMG method in stroke patients and healthy controls, plus explores how ccPAS with different timing affects that inhibition.

Quick facts

Study typeInterventional
Ages18 Years to 80 Years
SexAll
Enrollment20 (estimated)
SponsorThe Hong Kong Polytechnic University
Academic / other
Locations2 sites (Hong Kong and 1 other locations)
StatusRecruiting
StartedJuly 15, 2026
Main results expectedDecember 31, 2028
Study endsJune 1, 2029
Registry record updatedAugust 24, 2026
Trial IDNCT07431749 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18–80 years who have had a stroke (≥6 months ago) with some residual upper limb function and evocable MEPs from both motor areas, able to consent and communicate in Chinese.

Probably not a fit

Stroke survivors who do not have evocable MEPs, have substantial cognitive impairment, or have contraindications to TMS may not benefit from this intervention strategy.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project has two parts. First, it will test the reliability of a novel TMS-EEG-based interhemispheric inhibition measure and compare it to the established TMS-EMG method in stroke patients and healthy controls, with a repeat session after one week. Second, it will use a randomized-crossover design where stroke patients receive a single session of dual-coil ccPAS at three different interstimulus intervals to see how LTD-like, LTP-like, and sham protocols modulate the TMS-EEG IHI marker. The study aims to understand whether this noninvasive brain stimulation approach can reliably characterize and influence interhemispheric communication after stroke. Participants will undergo MRI verification of lesion location and repeated neurophysiological assessments to evaluate changes in cortical inhibition. Safety considerations follow standard TMS guidelines for stroke survivors. The Hong Kong Polytechnic University leads the study with no listed external collaborators.

Why it matters

Potential benefit: If successful, this approach could provide a reliable, noninvasive way to measure and potentially enhance post-stroke brain recovery by modulating interhemispheric inhibition.

How similar studies have gone: Previous ccPAS and TMS-EEG studies suggest potential modulatory effects on cortical circuits, but the combined reliability validation against TMS-EMG in post-stroke IHI is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* (1) have a diagnosis of ischemic or hemorrhagic stroke, with time after stroke onset≥6 months. For stroke patients, we will invite participants to receive a structural magnetic resonance imaging (MRI) at the University Research Facility in Behavioral and Systems Neuroscience to verify their actual lesion location; (2) aged between 18 and 80 years old; (3) with residual upper limb functions from 4-7 levels in the Functional Test for the Hemiplegic Upper Extremity (Hong Kong version); (4) have evocable MEP from both M1; (5) able to give informed written consent to participate in the study. (6) able to understand and communicate with Chinese.

Exclusion Criteria:

(1) any contraindications to TMS (screened by the safety checklist by Rossi); (2) any concomitant neurological disease; (3) any sign of moderate-to-severe cognitive problems, i.e., the abbreviated mental test Hong Kong version\<6 out of 10 points \[22\]; and (4) Modified Ashworth score\>2 in hand, wrist or elbow extensor muscle in their hemiparetic upper limbs.

In addition, a group of right-hand-dominant healthy adults, without any known neurological and psychiatric diseases, will be enrolled.

Where it's running

  • Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Recruiting
  • The Hong Kong Polytechnic University
    Hong Kong, Hong Kong
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.